HB 916: An Act amending the act of November 3, 2022 (P.L.2135, No.150), known as the Childhood Blood Lead Test Act, further providing for title of act, for legislative purpose, for definitions, for lead poisoning prevention, assessment and testing, for duties of department and for blood lead assessment and testing coverage.

Plain-language summary

HB 916 is a bill introduced in the Pennsylvania House on March 17, 2025. According to its official title, it concerns: An Act amending the act of November 3, 2022 (P.L.2135, No.150), known as the Childhood Blood Lead Test Act, further providing for title of act, for legislative purpose, for definitions, for lead poisoning prevention, assessment and testing, for duties of department and for blood lead assessment and testing coverage. Primary sponsor: José Giral (Democratic). It lists 13 additional sponsors. Most recent recorded action (June 11, 2026): Referred to Health & Human Services.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written